
High-Quality Tenofovir + Lamivudine + Dolutegravir Tablets for International Supply
Tenofovir + Lamivudine + Dolutegravir Tablets are among the most widely prescribed fixed-dose antiretroviral therapies used for the treatment and long-term management of HIV infection. This advanced triple-drug combination supports viral suppression, strengthens immune function, and improves treatment adherence through convenient once-daily dosing.
As a leading pharmaceutical exporter from India, we supply high-quality HIV medicines to hospitals, distributors, NGOs, healthcare institutions, wholesalers, and procurement agencies across international markets.
Composition of Tenofovir + Lamivudine + Dolutegravir Tablets
Each tablet commonly contains:
• Tenofovir Disoproxil Fumarate 300 mg
• Lamivudine 300 mg
• Dolutegravir 50 mg
This combination works by inhibiting HIV replication at multiple stages, helping improve treatment outcomes and patient quality of life.
Therapeutic Applications
Tenofovir + Lamivudine + Dolutegravir Tablets are indicated for:
HIV-1 infection treatment and management
First-line antiretroviral therapy (ART) regimens
Long-term viral suppression programs
Immune function support in HIV-positive patients
Public healthcare HIV treatment programs and institutional procurement
Key Patient Benefits
Effective Viral Suppression
Supports reduction of viral load when taken consistently according to medical guidance.
Improved Treatment Adherence
Single-tablet regimens reduce pill burden and simplify therapy.
Enhanced Immune Support
May help maintain and improve immune system function over time.
Convenient Administration
Once-daily dosing enhances patient convenience and compliance.
Globally Accepted Treatment Protocol
Frequently used in international HIV treatment guidelines and healthcare programs.
Dosage and Administration
Usually administered once daily or as directed by healthcare professionals
Tablets should be swallowed whole with water
Can generally be taken with or without food depending on physician recommendation
Patients should maintain strict treatment adherence for optimal outcomes
Dose adjustments should always be performed under medical supervision
Safety and Monitoring
Patients receiving treatment may require routine monitoring for:
Kidney function assessment
Liver function evaluation
Viral load monitoring
Drug interaction management
Long-term treatment effectiveness
Professional medical supervision is recommended throughout therapy.
Export Availability from India – Global Supply Network
We support pharmaceutical exports and supply solutions for international buyers, distributors, government tenders, NGOs, hospitals, and healthcare procurement organizations.
Export Markets Served
Africa:
South Africa, Kenya, Nigeria, Tanzania, Botswana, Mozambique, Zimbabwe, Ethiopia, Lesotho
Asia:
Philippines, Thailand, Nepal, Myanmar, UAE
North America:
United States, Canada
Europe:
United Kingdom, Germany, Netherlands
Latin America:
Brazil, Peru, Colombia
Our export support includes:
Bulk quantity supply
International documentation assistance
Commercial export support
Reliable packaging solutions
Global logistics coordination
Institutional and distributor supply programs
Order & Enquiry Information
For bulk orders, export enquiries, distribution partnerships, and procurement support:
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
Connect with us for reliable pharmaceutical export solutions from India and worldwide medicine supply support.
Tenofovir + Lamivudine + Dolutegravir Tablets are among the most widely prescribed fixed-dose antiretroviral therapies used for the treatment and long-term management of HIV infection. This advanced triple-drug combination supports viral suppression, strengthens immune function, and improves treatment adherence through convenient once-daily dosing.
As a leading pharmaceutical exporter from India, we supply high-quality HIV medicines to hospitals, distributors, NGOs, healthcare institutions, wholesalers, and procurement agencies across international markets.
Composition of Tenofovir + Lamivudine + Dolutegravir Tablets
Each tablet commonly contains:
• Tenofovir Disoproxil Fumarate 300 mg
• Lamivudine 300 mg
• Dolutegravir 50 mg
This combination works by inhibiting HIV replication at multiple stages, helping improve treatment outcomes and patient quality of life.
Therapeutic Applications
Tenofovir + Lamivudine + Dolutegravir Tablets are indicated for:
HIV-1 infection treatment and management
First-line antiretroviral therapy (ART) regimens
Long-term viral suppression programs
Immune function support in HIV-positive patients
Public healthcare HIV treatment programs and institutional procurement
Key Patient Benefits
Effective Viral Suppression
Supports reduction of viral load when taken consistently according to medical guidance.
Improved Treatment Adherence
Single-tablet regimens reduce pill burden and simplify therapy.
Enhanced Immune Support
May help maintain and improve immune system function over time.
Convenient Administration
Once-daily dosing enhances patient convenience and compliance.
Globally Accepted Treatment Protocol
Frequently used in international HIV treatment guidelines and healthcare programs.
Dosage and Administration
Usually administered once daily or as directed by healthcare professionals
Tablets should be swallowed whole with water
Can generally be taken with or without food depending on physician recommendation
Patients should maintain strict treatment adherence for optimal outcomes
Dose adjustments should always be performed under medical supervision
Safety and Monitoring
Patients receiving treatment may require routine monitoring for:
Kidney function assessment
Liver function evaluation
Viral load monitoring
Drug interaction management
Long-term treatment effectiveness
Professional medical supervision is recommended throughout therapy.
Export Availability from India – Global Supply Network
We support pharmaceutical exports and supply solutions for international buyers, distributors, government tenders, NGOs, hospitals, and healthcare procurement organizations.
Export Markets Served
Africa:
South Africa, Kenya, Nigeria, Tanzania, Botswana, Mozambique, Zimbabwe, Ethiopia, Lesotho
Asia:
Philippines, Thailand, Nepal, Myanmar, UAE
North America:
United States, Canada
Europe:
United Kingdom, Germany, Netherlands
Latin America:
Brazil, Peru, Colombia
Our export support includes:
Bulk quantity supply
International documentation assistance
Commercial export support
Reliable packaging solutions
Global logistics coordination
Institutional and distributor supply programs
Order & Enquiry Information
For bulk orders, export enquiries, distribution partnerships, and procurement support:
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
Connect with us for reliable pharmaceutical export solutions from India and worldwide medicine supply support.
Keywords







